Doxorubicin hydrochloride

Drug ingredient

CAS 25316-40-9

This chemical is an active pharmaceutical ingredient used in FDA-regulated drugs.

Molecular structure of 25316-40-9
1 HCl
US productionNot reported
Top sourceNo public record

This chemical is not on EPA’s Toxic Substances Control Act inventory, the list behind EPA’s production survey.

Why supply is unknown

Where It Comes From

EPA and Census publish no US supply data for this chemical.

25 FDA-registered drug labelers
Actavis Pharma, Inc.
Alembic Pharmaceuticals Inc.
Alembic Pharmaceuticals Limited
Amneal Pharmaceuticals LLC
Baxter Healthcare Company
Baxter Healthcare Corporation
BluePoint Laboratories
Dr. Reddy's Laboratories Inc
Fresenius Kabi USA, LLC
Gemini PharmChem Mannheim GmbH
Gland Pharma Limited
GlaxoSmithKline Manufacturing SpA
Hikma Pharmaceuticals USA Inc.
Lupin Pharmaceuticals, Inc.
Meiji Seika Pharma Co., Ltd.
MicroBiopharm Japan Co., Ltd.
Mylan Institutional LLC
NorthStar RxLLC
Olon SpA
Pfizer Laboratories Div Pfizer Inc
Sagent Pharmaceuticals
Sicor S.r.l.
Sun Pharmaceutical Industries, Inc.
Zydus Lifesciences Limited
Zydus Pharmaceuticals USA Inc.

Why It Matters

Sectors
Health
Downstream Uses

Appears in 4 drug and cosmetic product listings (FDA).

  • •Doxorubicin Hydrochloride
  • •Doxil
  • •Doxorubicin Hydrochloride Liposome
  • •doxorubicin hydrochloride, Liposomal
FDA Shortage Status
No FDA shortage records

Chemical Identity

CAS25316-40-9
PubChem CID443939
DTXSIDDTXSID3030636
FormulaC27H30ClNO11
Mol. Weight580 g/mol
SMILESCC1C(C(CC(O1)OC2CC(CC3=C2C(=C4C(=C3O)C(=O)C5=C(C4=O)C(=CC=C5)OC)O)(C(=O)CO)O)N)O.Cl

Data Sources

Brief citations

Doxorubicin hydrochloride (CAS 25316-40-9) https://chemicalindependence.com/chemical/25316-40-9/ PubChem: 443939. Retrieved 2026-04-07. https://pubchem.ncbi.nlm.nih.gov/compound/443939 FDA National Drug Code directory: CAS 25316-40-9. Retrieved 2026-04-25. https://open.fda.gov/data/ndc/ FDA National Drug Code directory: bulk match. Retrieved 2026-04-07. https://open.fda.gov/data/ndc/